After Hours Summary: ORCL -3.5% following earnings/guidance, MRTX +68% on clinical trial updateAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: LPTH +16.7%, ASPU +3.9%, KANG +2.4%, SPA +1.2% (light volume)
Companies trading higher in after hours in reaction to news: MRTX +68.4% (presents 'positive' preliminary data from on-going clinical trials of sitravatinib in non-small cell lung cancer), TNXP +14.5% (receives a European patent protecting the use of Tonmya for the treatment of PTSD), GNW +7.5% (Virginia State Corporation Commission, Bureau of Insurance, approved the proposed acquisition of control by Oceanwide of Genworth's Virginia-domiciled insurance companies), OCLR +2.6% (initiated after hours with a Strong Buy at Raymond James), SN +2.2% (CEO and President each purchased 100K shares), BTX +1.7% (ticking higher; announced the successful conclusion of the challenge to two key patents before the European Patent Office Opposition division), FOLD +1.3% (Health Canada approved the oral precision medicine Galafold for long-term treatment of adults with a confirmed diagnosis of Fabry disease and who have an alpha-Gal A mutation determined to be amenable by an in vitro assay), TWO +1% (Two Harbors Investment declared special dividend to distribute shares of Granite Point Mortgage Trust and approved a one-for-two reverse stock split)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: ORCL -3.5%
Companies trading lower in after hours in reaction to news: TTOO -19.4% (commences common stock offering), MRNS -2.5% (to offer and sell shares of its common stock in an underwritten public offering), INBK -1.3% (light volume; commences an underwritten public offering of approx. $40 mln of the Co's common stock), Q -1.2% (launches secondary public offering of 9 mln shares of common stock by stockholders including affiliates of TPG Global, CPP Investment Board, investment funds associated with Bain Capital and Leonard Green), MTW -0.6% (plans to undertake reverse stock split of Manitowoc's common stock at a ratio of 1-for-4), SAVE -0.5% (reported August Traffic (revenue passenger miles) +20.6% y/y on a capacity increase of 21.9%; expect Irma impact to be significant), BMRN -0.3% (advised by the FDA that it is not currently planning to hold an advisory committee meeting to discuss the Biologics License Application for pegvaliase)